Literature DB >> 21910689

Targeted polyubiquitylation of RASSF1C by the Mule and SCFβ-TrCP ligases in response to DNA damage.

Xin Zhou1, Ting-Ting Li, Xu Feng, Esther Hsiang, Yue Xiong, Kun-Liang Guan, Qun-Ying Lei.   

Abstract

RASSF1A [Ras association (RalGDS/AF-6) domain family member 1A] and RASSF1C are two ubiquitously expressed isoforms of the RASSF1 gene. The promoter of RASSF1A is frequently hypermethylated, resulting in inactivation in various human cancers. RASSF1A is implicated in the regulation of apoptosis, microtubule stability and cell cycle arrest. However, little is known about the regulation and function of RASSF1C. In the present study we show that exogenously expressed RASSF1C is a very unstable protein that is highly polyubiquitylated and degraded via the proteasome. Furthermore, RASSF1C degradation is enhanced when cells are exposed to stress signals, such as UV irradiation. Mule, a HECT (homologous with E6-associated protein C-terminus) family E3 ligase, but not SCFβ-TrCP [where SCF is Skp1 (S-phase kinase-associated protein 1)/cullin/F-box and β-TrCP is β-bransducin repeat-containing protein] or CUL4 (cullin 4)-DDB1 (damage-specific DNA-binding protein 1), is the E3 ligase for RASSF1C under normal conditions, whereas both Mule and SCFβ-TrCP target RASSF1C degradation in response to UV irradiation. GSK3 (glycogen synthase kinase 3) phosphorylates RASSF1C to promote RASSF1C degradation subsequently, which is negatively regulated by the PI3K (phosphoinositide 3-kinase)/Akt pathway. Thus the present study reveals a novel regulation of RASSF1C and the potentially important role of RASSF1C in DNA damage responses.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21910689      PMCID: PMC4610364          DOI: 10.1042/BJ20111500

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  45 in total

Review 1.  The renaissance of GSK3.

Authors:  P Cohen; S Frame
Journal:  Nat Rev Mol Cell Biol       Date:  2001-10       Impact factor: 94.444

2.  Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features.

Authors:  R Maruyama; S Toyooka; K O Toyooka; K Harada; A K Virmani; S Zöchbauer-Müller; A J Farinas; F Vakar-Lopez; J D Minna; A Sagalowsky; B Czerniak; A F Gazdar
Journal:  Cancer Res       Date:  2001-12-15       Impact factor: 12.701

3.  Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta.

Authors:  M J Hart; R de los Santos; I N Albert; B Rubinfeld; P Polakis
Journal:  Curr Biol       Date:  1998-05-07       Impact factor: 10.834

4.  Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.

Authors:  M G Lee; H Y Kim; D S Byun; S J Lee; C H Lee; J I Kim; S G Chang; S G Chi
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

Review 5.  PTEN and myotubularin: novel phosphoinositide phosphatases.

Authors:  T Maehama; G S Taylor; J E Dixon
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

Review 6.  The tumor suppressor RASSF1A in human carcinogenesis: an update.

Authors:  R Dammann; U Schagdarsurengin; C Seidel; M Strunnikova; M Rastetter; K Baier; G P Pfeifer
Journal:  Histol Histopathol       Date:  2005-04       Impact factor: 2.303

7.  In vivo protein biotinylation for identification of organ-specific antigens accessible from the vasculature.

Authors:  Jascha-N Rybak; Anna Ettorre; Brigitte Kaissling; Raffaella Giavazzi; Dario Neri; Giuliano Elia
Journal:  Nat Methods       Date:  2005-03-23       Impact factor: 28.547

8.  Glycogen synthase kinase 3beta phosphorylates p21WAF1/CIP1 for proteasomal degradation after UV irradiation.

Authors:  Ji Young Lee; Su Jin Yu; Yun Gyu Park; Joon Kim; Jeongwon Sohn
Journal:  Mol Cell Biol       Date:  2007-02-05       Impact factor: 4.272

9.  RASSF1A interacts with microtubule-associated proteins and modulates microtubule dynamics.

Authors:  Ashraf Dallol; Angelo Agathanggelou; Sarah L Fenton; Jalal Ahmed-Choudhury; Luke Hesson; Michele D Vos; Geoffrey J Clark; Julian Downward; Eamonn R Maher; Farida Latif
Journal:  Cancer Res       Date:  2004-06-15       Impact factor: 12.701

10.  RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein.

Authors:  David Matallanas; David Romano; Karen Yee; Katrin Meissl; Lucia Kucerova; Daniela Piazzolla; Manuela Baccarini; J Keith Vass; Walter Kolch; Eric O'neill
Journal:  Mol Cell       Date:  2007-09-21       Impact factor: 17.970

View more
  11 in total

1.  DNA-PK facilitates piggyBac transposition by promoting paired-end complex formation.

Authors:  Yan Jin; Yaohui Chen; Shimin Zhao; Kun-Liang Guan; Yuan Zhuang; Wenhao Zhou; Xiaohui Wu; Tian Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-23       Impact factor: 11.205

2.  Preventing p38 MAPK-mediated MafA degradation ameliorates β-cell dysfunction under oxidative stress.

Authors:  Ilham El Khattabi; Arun Sharma
Journal:  Mol Endocrinol       Date:  2013-05-09

3.  RASSF1 Polymorphisms in Cancer.

Authors:  Marilyn Gordon; Mohamed El-Kalla; Shairaz Baksh
Journal:  Mol Biol Int       Date:  2012-05-31

4.  DNA damage-induced activation of CUL4B targets HUWE1 for proteasomal degradation.

Authors:  Juan Yi; Guang Lu; Li Li; Xiaozhen Wang; Li Cao; Ming Lin; Sha Zhang; Genze Shao
Journal:  Nucleic Acids Res       Date:  2015-04-16       Impact factor: 16.971

5.  SIRT2 activates G6PD to enhance NADPH production and promote leukaemia cell proliferation.

Authors:  Shuang-Nian Xu; Tian-Shi Wang; Xi Li; Yi-Ping Wang
Journal:  Sci Rep       Date:  2016-09-02       Impact factor: 4.379

6.  A novel P53/POMC/Gαs/SASH1 autoregulatory feedback loop activates mutated SASH1 to cause pathologic hyperpigmentation.

Authors:  Ding'an Zhou; Zhiyun Wei; Zhongshu Kuang; Huangchao Luo; Jiangshu Ma; Xing Zeng; Ke Wang; Beizhong Liu; Fang Gong; Jing Wang; Shanchuan Lei; Dongsheng Wang; Jiawei Zeng; Teng Wang; Yong He; Yongqiang Yuan; Hongying Dai; Lin He; Qinghe Xing
Journal:  J Cell Mol Med       Date:  2016-11-25       Impact factor: 5.310

Review 7.  Ubiquitin-Dependent Regulation of the Mammalian Hippo Pathway: Therapeutic Implications for Cancer.

Authors:  Thanh Hung Nguyen; Jan-Michael Kugler
Journal:  Cancers (Basel)       Date:  2018-04-17       Impact factor: 6.639

8.  RASSF Signalling and DNA Damage: Monitoring the Integrity of the Genome?

Authors:  Simon F Scrace; Eric O'Neill
Journal:  Mol Biol Int       Date:  2012-04-11

9.  RASSF1A Site-Specific Methylation Hotspots in Cancer and Correlation with RASSF1C and MOAP-1.

Authors:  Natalia Volodko; Mohamed Salla; Alaa Zare; El-Arbi Abulghasem; Krista Vincent; Matthew G K Benesch; Todd P W McMullen; Oliver F Bathe; Lynne Postovit; Shairaz Baksh
Journal:  Cancers (Basel)       Date:  2016-06-10       Impact factor: 6.639

Review 10.  A partnership with the proteasome; the destructive nature of GSK3.

Authors:  Holly Robertson; John D Hayes; Calum Sutherland
Journal:  Biochem Pharmacol       Date:  2017-11-01       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.